Adele Marrangoni

2.7k total citations
28 papers, 2.0k citations indexed

About

Adele Marrangoni is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Adele Marrangoni has authored 28 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Immunology. Recurrent topics in Adele Marrangoni's work include Ovarian cancer diagnosis and treatment (8 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Advanced Proteomics Techniques and Applications (3 papers). Adele Marrangoni is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Advanced Proteomics Techniques and Applications (3 papers). Adele Marrangoni collaborates with scholars based in United States, Japan and Sweden. Adele Marrangoni's co-authors include Anna Lokshin, Elieser Gorelik, Vera Levina, Lyudmila Velikokhatnaya, Brian M. Nolen, Richard DeMarco, Matthew Winans, Zoya R. Yurkovetsky, Douglas Landsittel and Ronald B. Herberman and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Adele Marrangoni

28 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adele Marrangoni United States 22 861 855 465 363 354 28 2.0k
Brian M. Nolen United States 21 577 0.7× 547 0.6× 282 0.6× 464 1.3× 364 1.0× 28 1.6k
Kae Hashimoto Japan 27 632 0.7× 1.2k 1.4× 518 1.1× 232 0.6× 781 2.2× 73 2.1k
Ryusuke Murakami Japan 19 1.2k 1.4× 606 0.7× 952 2.0× 450 1.2× 393 1.1× 78 2.3k
Karl‐Henning Kalland Norway 34 658 0.8× 1.5k 1.8× 341 0.7× 131 0.4× 520 1.5× 81 2.5k
Antonella Romanini Italy 23 788 0.9× 436 0.5× 305 0.7× 226 0.6× 171 0.5× 73 1.7k
Karin Sundfeldt Sweden 30 521 0.6× 1.3k 1.5× 327 0.7× 927 2.6× 606 1.7× 91 2.7k
Esther Elishaev United States 24 498 0.6× 582 0.7× 510 1.1× 528 1.5× 388 1.1× 70 1.8k
Anne M. Øyan Norway 37 809 0.9× 1.6k 1.9× 347 0.7× 254 0.7× 769 2.2× 75 2.9k
Hiromasa Kuroda Japan 20 573 0.7× 466 0.5× 440 0.9× 218 0.6× 226 0.6× 42 1.5k

Countries citing papers authored by Adele Marrangoni

Since Specialization
Citations

This map shows the geographic impact of Adele Marrangoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele Marrangoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele Marrangoni more than expected).

Fields of papers citing papers by Adele Marrangoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adele Marrangoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele Marrangoni. The network helps show where Adele Marrangoni may publish in the future.

Co-authorship network of co-authors of Adele Marrangoni

This figure shows the co-authorship network connecting the top 25 collaborators of Adele Marrangoni. A scholar is included among the top collaborators of Adele Marrangoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adele Marrangoni. Adele Marrangoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nolen, Brian M., et al.. (2014). Urinary Protein Biomarkers in the Early Detection of Lung Cancer. Cancer Prevention Research. 8(2). 111–119. 32 indexed citations
2.
Nolen, Brian M., Lidiya Orlichenko, Adele Marrangoni, et al.. (2013). An Extensive Targeted Proteomic Analysis of Disease-Related Protein Biomarkers in Urine from Healthy Donors. PLoS ONE. 8(5). e63368–e63368. 24 indexed citations
3.
Clendenen, Tess V., Alan A. Arslan, Anna Lokshin, et al.. (2013). Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes & Control. 24(4). 741–748. 21 indexed citations
4.
Furda, Amy M., Adele Marrangoni, Anna Lokshin, & Bennett Van Houten. (2012). Oxidants and not alkylating agents induce rapid mtDNA loss and mitochondrial dysfunction. DNA repair. 11(8). 684–692. 78 indexed citations
5.
Clendenen, Tess V., Alan A. Arslan, Anna Lokshin, et al.. (2010). Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Research Notes. 3(1). 302–302. 30 indexed citations
6.
Nolen, Brian M., Liudmila Velikokhatnaya, Adele Marrangoni, et al.. (2010). Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecologic Oncology. 117(3). 440–445. 126 indexed citations
7.
Levina, Vera, Adele Marrangoni, Tingting Wang, et al.. (2010). Abstract 4272: Elimination of human lung cancer stem cells through targeting of the SCF-c-kit autocrine signaling loop. Cancer Research. 70(8_Supplement). 4272–4272. 1 indexed citations
8.
Levina, Vera, Adele Marrangoni, Tingting Wang, et al.. (2009). Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor–c-kit Autocrine Signaling Loop. Cancer Research. 70(1). 338–346. 124 indexed citations
9.
Linkov, Faina, Yian Gu, Alan A. Arslan, et al.. (2009). Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. European Cytokine Network. 20(1). 21–26. 31 indexed citations
10.
Nolen, Brian M., et al.. (2009). Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay. Journal of Immunological Methods. 344(2). 116–120. 10 indexed citations
11.
Levina, Vera, Adele Marrangoni, Richard DeMarco, Elieser Gorelik, & Anna Lokshin. (2008). Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties. PLoS ONE. 3(8). e3077–e3077. 347 indexed citations
12.
Levina, Vera, Adele Marrangoni, Richard DeMarco, Elieser Gorelik, & Anna Lokshin. (2008). Multiple effects of TRAIL in human carcinoma cells: Induction of apoptosis, senescence, proliferation, and cytokine production. Experimental Cell Research. 314(7). 1605–1616. 17 indexed citations
13.
Nolen, Brian M., et al.. (2008). A serum based analysis of ovarian epithelial tumorigenesis. Gynecologic Oncology. 112(1). 47–54. 31 indexed citations
14.
Linkov, Faina, Robert L. Ferris, Zoya R. Yurkovetsky, et al.. (2008). Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases. PROTEOMICS - CLINICAL APPLICATIONS. 2(12). 1575–1585. 38 indexed citations
15.
Gu, Yian, Anne Zeleniuch‐Jacquotte, Faina Linkov, et al.. (2008). Reproducibility of serum cytokines and growth factors. Cytokine. 45(1). 44–49. 58 indexed citations
16.
Linkov, Faina, Zoya R. Yurkovetsky, Adele Marrangoni, et al.. (2007). Early Detection of Head and Neck Cancer: Development of a Novel Screening Tool Using Multiplexed Immunobead-Based Biomarker Profiling. Cancer Epidemiology Biomarkers & Prevention. 16(1). 102–107. 94 indexed citations
17.
Lokshin, Anna, Zoya R. Yurkovetsky, Brian M. Nolen, et al.. (2006). Multimarker assay for early diagnosis of ovarian cancer. Cancer Research. 66. 155–155. 3 indexed citations
18.
Lokshin, Anna, Douglas Landsittel, Adele Marrangoni, et al.. (2006). Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecologic Oncology. 102(2). 244–251. 113 indexed citations
19.
Gorelik, Elieser, Robert P. Edwards, Xin Feng, et al.. (2004). IL‐12 receptor‐mediated upregulation of FasL in human ovarian carcinoma cells. International Journal of Cancer. 112(4). 620–627. 14 indexed citations
20.
Marrangoni, Adele, et al.. (2003). Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines. Cancer Letters. 190(1). 61–72. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian M. Nolen Breakdown of academic impact, for papers by Kae Hashimoto Breakdown of academic impact, for papers by Ryusuke Murakami Breakdown of academic impact, for papers by Karl‐Henning Kalland Breakdown of academic impact, for papers by Antonella Romanini Breakdown of academic impact, for papers by Karin Sundfeldt Breakdown of academic impact, for papers by Esther Elishaev Breakdown of academic impact, for papers by Anne M. Øyan Breakdown of academic impact, for papers by Hiromasa Kuroda
Rankless by CCL
2026